Stomach Cancer: How Immunotherapy and Targeted Therapy are Changing Treatment

The approval of a targeted therapy and an immunotherapy drug for some patients with advanced stomach cancer reflects recent new approaches to this difficult-to-treat cancer that hasn’t had many therapeutic advances in recent years. Stomach cancer, uncommon in the United States but a leading cause of cancer death globally, causes few definitive symptoms in early … Read more

When Is Weight Loss a Sign of Cancer?

Everyone’s weight fluctuates over the course of life, rising or falling with changes in diet and exercise, and with the normal slowing of metabolism that occurs as we age. When weight loss occurs for no apparent reason – especially if the drop is dramatic – a variety of physical or psychological causes could be responsible. … Read more

What’s New in Cancer Immunotherapy?

Keeping up with progress in the field of cancer immunotherapy requires paying close attention. The number of approved drugs that help the body’s immune system fight cancer continues to grow, as does the list of different cancers in which immunotherapy is proving effective – in some cases yielding dramatically longer-lasting benefits than standard chemotherapy. A … Read more

Immunotherapy, Targeted Drugs, Brain Cancer Research Among Highlights at Cancer Meeting

Eagerly awaited new data from trials of immunotherapy drugs, vaccines to treat brain tumors, and improved treatments for blood cancers sparked waves of optimism at the year’s biggest cancer meeting. The 2015 annual meeting of the American Society of Clinical Oncology (ASCO) drew about 30,000 cancer specialists to Chicago May 29 – June 2. Immunotherapy, … Read more

50 Years of Discovery: Advances in Colorectal Cancer Treatment

The fight against cancers of the digestive system – including colorectal, stomach, esophageal, hepatic, and pancreatic cancers – has made significant progress in the past 50 years, especially in prevention and early diagnosis of colorectal cancer, where screening with tests such as colonoscopies is continuing to make a major impact. “In some areas we have done … Read more


巴雷特食管(Barrett’s Esophagus)是胃食管反流病(gastroesophageal reflux disease, 简称GERD)的并发症,某些情况下,它可能会成为食管癌(esophageal cancer)的前兆。当慢性返流(chronic regurgitation)的胃酸进入食管,导致食管(从口腔到胃的食物输送管)的表面组织开始出现类似肠道表面组织的特征时,巴雷特食管病症就会发生。


在治疗之前、之中和之后,食道癌(esophageal cancer)患者在进食方面会遇到一些挑战。患者或许需要接受放射疗法(radiation therapy)、化学疗法(chemotherapy)、手术(surgery)或上述任何组合疗法,以抗击癌症。食道癌及其治疗也会使患者的食道变窄和(或)干燥、疼痛和发炎,这或许会让患者在吞咽时感到痛苦。因此,患者具有体重降低和疲惫倾向,这是缺少营养的结果。